Literature DB >> 32277380

Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges.

Patrícia Pimentel de Barros1, Rodnei Dennis Rossoni2, Cheyenne Marçal de Souza2, Liliana Scorzoni2, Juliana De Camargo Fenley2, Juliana Campos Junqueira2.   

Abstract

Fungi of the genus Candida are important etiological agents of superficial and life-threatening infections in individuals with a compromised immune system. One of the main characteristics of Candida is its ability to form highly drug tolerance biofilms in the human host. Biofilms are a dynamic community of multiple cell types whose formation over time is orchestrated by a network of transcription regulators. In this brief review, we provide an update of the processes involved in biofilm formation by Candida spp. (formation, treatment, and control), as well as the transcriptional circuitry that regulates its development and interactions with other microorganisms. Candida albicans is known to build mixed species biofilms with other Candida species and with various other bacterial species in different host niches. Taken together, these properties play a key role in Candida pathogenesis. In addition, this review gathers recent studies with new insights and perspectives for the treatment and control of Candida biofilms.

Entities:  

Keywords:  Alternative treatment; Biofilms; Candida spp.; Polymicrobial biofilms; Transcriptional circuitry

Mesh:

Year:  2020        PMID: 32277380     DOI: 10.1007/s11046-020-00445-w

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  9 in total

1.  Antibiofilm Activity of Essential Fatty Acids Against Candida albicans from Vulvovaginal Candidiasis and Bloodstream Infections.

Authors:  Shuai Wang; Peng Wang; Jun Liu; Chunxia Yang; Qiangyi Wang; Mingze Su; Ming Wei; Li Gu
Journal:  Infect Drug Resist       Date:  2022-08-03       Impact factor: 4.177

2.  Production and Isolation of the Candida Species Biofilm Extracellular Matrix.

Authors:  Marienella Hereidia; David Andes
Journal:  Methods Mol Biol       Date:  2022

3.  Oral Colonization by Candida Species in Patients with Multiple Sclerosis.

Authors:  Eliana Tomomi Shimabukuro da Cunha; Lívia Mara Alves Figueiredo-Godoi; Diogo Haddad Santos; Rafael Paterno Castello Dias Carneiro; Guilherme Sciascia do Olival; Patrícia Pimentel de Barros; Keila Narimatsu; Charles Peter Tilbery; Juliana Campos Junqueira
Journal:  Mycopathologia       Date:  2020-08-27       Impact factor: 2.574

4.  Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition.

Authors:  Bin Zhu; Zhen Li; Hongmei Yin; Jun Hu; Yingjun Xue; Guanyi Zhang; Xin Zheng; Weiqin Chen; Xiaobo Hu
Journal:  Microbiol Spectr       Date:  2022-03-17

Review 5.  Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis.

Authors:  Carmen Rodríguez-Cerdeira; Erick Martínez-Herrera; Miguel Carnero-Gregorio; Adriana López-Barcenas; Gabriella Fabbrocini; Monika Fida; May El-Samahy; José Luís González-Cespón
Journal:  Front Microbiol       Date:  2020-11-11       Impact factor: 5.640

6.  Ethyl Acetate Fraction of Punica granatum and Its Galloyl-HHDP-Glucose Compound, Alone or in Combination with Fluconazole, Have Antifungal and Antivirulence Properties against Candida spp.

Authors:  Aline Michelle Silva Mendonça; Cristina de Andrade Monteiro; Roberval Nascimento Moraes-Neto; Andrea Souza Monteiro; Renata Mondego-Oliveira; Camila Evangelista Carnib Nascimento; Luís Cláudio Nascimento da Silva; Lidio Gonçalves Lima-Neto; Rafael Cardoso Carvalho; Eduardo Martins de Sousa
Journal:  Antibiotics (Basel)       Date:  2022-02-18

7.  Origanum vulgare L. essential oil inhibits virulence patterns of Candida spp. and potentiates the effects of fluconazole and nystatin in vitro.

Authors:  Mario Díaz-Dosque; Alfredo Molina-Berríos; Camila Cid-Chevecich; Andrea Müller-Sepúlveda; José Antonio Jara; Rodrigo López-Muñoz; Rocío Santander; Mauricio Budini; Alejandro Escobar; Raúl Quijada; Alfredo Criollo
Journal:  BMC Complement Med Ther       Date:  2022-02-09

Review 8.  Petrositis caused by fluconazole-resistant candida: case report and literature review.

Authors:  Ling Jin; Shuangxi Liu; Shiwang Tan; Yang Wang; Yumin Zhao; Shaoqing Yu
Journal:  BMC Infect Dis       Date:  2022-07-27       Impact factor: 3.667

9.  Evaluation of the biofilm life cycle between Candida albicans and Candida tropicalis.

Authors:  María Belén Atiencia-Carrera; Fausto Sebastián Cabezas-Mera; Karla Vizuete; Alexis Debut; Eduardo Tejera; António Machado
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.